The company's founder's work was quoted in a special report on the gene line in February!
Release time:
2021-03-10 13:32

It's an honor to be on the gene line.2In several articles of the month's special report, the author of the company's founder, lawyer Hou Qingchen, was quoted as saying that [on the industrialization of patented medicine-Special Study on Chinese Patent Law] Book B, using the literature data of our company and our partner Qingchen Law Firm. Readers who are interested in the text are welcome to click on the link below:
1. China's Patent Law Reform Drives the Development of Pharmaceutical Industry (Part I): Generic Drugs Are Bulk, Insufficient Incentives for Transformation?
https://geneonline.news/china-patent-biomedical-industry-part1/
2. the reform of China's patent laws and regulations to promote the development of the pharmaceutical industry (below): patent linkage system, patent term compensation.
https://geneonline.news/china-patent-biomedical-industry-part2/
3. biotechnology talents and new ventures flood into China? Deciphering the industrial dynamics of China's biomedical markethttps://geneonline.news/china-pharma-trend/

Online, https, China, geneonline.news, Patents, Regulations, Links, Pharmaceutical Industry, Development, Company
Room 409, Building 23, Zhongke Innovation Plaza, No. 150 Pubin Road, Jiangbei New District, Nanjing, Jiangsu Province
Copyright ◎ Nanjing Huaxun Intellectual Property Consultants Co., Ltd.